baber/WOPTO huggingface dataset:
Patent NZ-532954-A (NZ)
Title: Method for the transmission of signal tones in heterogeneous networks, device and computer programme product
Inventor: BAUMANN THOMAS
IPC: H04L29/06
Filed: 2002-08-30
Abstract: A method for selecting a transfer procedure for DTMF signal tones in heterogeneous networks is disclosed. The method includes the steps of: (a) notifying of the transfer procedure that can be used for the signal tones, whereby the signal tones are supported by a first transfer exchange located between a packet network and a circuit network, from the first transfer exchange over a signalling network to a second transfer exchange between the packet network and the circuit network, (b) the second transfer exchange selects a transfer procedure for DTMF signal tones which is supported both by the first transfer exchange and the second transfer exchange, and (c) notifying the first transfer exchange of the transfer procedure that is selected by the second transfer exchange.
Patent NZ-533399-A (NZ)
Title: Improvements in packaging and packaging methods relating thereto
Inventor: PATTERSON MILES ROYLANCE
Filed: 2004-06-04
Abstract: A modified atmosphere pack is disclosed that contains at least a meat cut that is at least partially enveloped by a flexible sheet that includes a breather layer of gas permeable configuration, and a pad provided in a location to be capable of being in fluid connection with the meat cut. The pad has an absorbent material and a ply of plastic film. The film is located intermediate of (i) the meat cut and said flexible sheet and (ii) part of the pack.
Patent NZ-535669-A (NZ)
Title: Compact folding chair
Inventor: TSANG SHING CHI
IPC: A47C4/16
Filed: 2003-03-10
Abstract: A compact folding chair comprises a sitting base (19) pivotally connected to a backrest (17), which is supported by two sets of legs (20, 21) and locking mechanism (14, 15, 16). A set of level blocks (39), a pair of sliding bars (26) and a pair of tie bars (36) are arranged so that the chair can be compactly folded. In an alternative embodiment, the backrest is divided into two portions (17a, 17b) and incorporates arm rests (18) having a track (22) with a plurality of stoppers such that the angle of the upper backrest portion (17a) can be adjusted. In this embodiment, a second set of level blocks (37), sliding bars (35), and tie bars (25) are used.
Patent NZ-537462-A (NZ)
Title: An alterable solar collector
Inventor: JING MING
IPC: F24S10/70
Filed: 2005-01-05
Abstract: A solar collector of a solar water heating system comprises of a conduit formed by two circular cross-sectioned manifolds running parallel with each other. The manifolds are able to rotate vertically about the central line of the manifolds. The manifolds have (i) a plurality of T-shaped members (ii) a plurality of seal means connecting the T-shaped members together in a watertight way (iii) at least one heat insulate means covering outside of the T-shaped members and the seal means and (iv) at least one cover means supporting and protecting the heat insulate means, as well as the T-shaped members and the seal means inside the heat insulate means. The solar collector also comprises of a plurality of solar absorbers perpendicularly positioned along the conduit and connected to the side holes of the T-shaped members of the manifolds of the conduit, at least one bottom support means at each side of the conduit holding the low ends of the solar absorbers to keep them in position, and at least two connection means riding on a roof on which the solar collector is installed to connect the bottom support means to the manifolds.
Patent NZ-539505-A (NZ)
Title: Method of administration of IGF-I
Inventor: CLARK ROSS G
Filed: 1996-05-09
Abstract: Disclosed is the use of insulin-like growth factor-I (IGF-I) in the preparation of a medicament for administering to a mammal so as to sustain its biological response in the treatment of a chronic disorder in the mammal wherein the medicament is formulated for administration according to a dosing regime providing IGF-I to the mammal to provide an exposure to IGF-I that is continuous or at least once a day consecutively over a period of days that provides the maximum biological response in the mammal, then discontinuing said administration by means of a continual lack of treatment or a lack of treatment for consecutive days over a period of days equal to or less than the number of days during which the IGF-I was previously administered, then administering IGF-I to the mammal to provide an exposure to IGF-I that is continuous or at least once a day consecutively over a period of days that provides the maximum biological response in the mammal, then discontinuing said administration by means of a continual lack of treatment or a lack of treatment for consecutive days over a period of days equal to or less than the number of days during which the IGF-I was just previously administered, and repeating this pattern of administration and discontinuance of administration for as long as necessary to achieve or maintain sustained biological response in the mammal.
Patent NZ-546793-A (NZ)
Title: Food product and process for reducing oil and fat content cooked food
Inventor: KELLEHER STEPHEN D
IPC: A23L13/70
Filed: 2004-11-18
Abstract: Disclosed is a process for cooking a food in oil and/or fat. A dry protein mixture, a dry alkaline protein mixture, an aqueous alkaline protein mixture or an aqueous acidic protein is added to a food prior to cooking. The dry protein mixture, dry alkaline protein mixture, aqueous alkaline protein mixture and aqueous acidic protein solution comprise myofibrillar proteins and sarcoplasmic proteins substantially free of myofibrils and sarcomeres. The amount of oil and/or fat absorbed by the food during cooking is substantially reduced.
Patent NZ-547648-A (NZ)
Title: Elevator suspension arrangement
Inventor: MUSTALAHTI JORMA
IPC: B66B11/08
Filed: 2004-11-22
Abstract: A suspension arrangement for an elevator 1, the suspension arrangement comprising a hoisting machine 4, hoisting ropes 3, a stiffener, a first bearing, and a pulley, wherein the hoisting machine 4 includes a stator frame, and an assembly, wherein the stator frame is adapted to be secured in an elevator shaft, wherein the assembly includes a traction sheave 5, and a rotor frame, wherein the traction sheave 5 is fixed to the rotor frame, wherein the assembly is adapted to rotate with respect to the stator frame, wherein the hoisting machine 4 is secured to the stiffener bracing the stator frame so that the assembly is between the stator frame and the stiffener, wherein the stiffener includes a first support adapted to mount the first bearing, wherein the first bearing is adapted to mount the pulley, wherein the pulley, the first bearing, the hoisting machine 4, and the stiffener are adapted to automatically align the pulley with the traction sheave 5 when the pulley is mounted on the first bearing and the hoisting machine 4 is secured to the stiffener, and wherein the suspension arrangement is adapted to suspend an elevator 1 without a counterweight.
Patent NZ-547991-A (NZ)
Title: Enzyme inhibiting sprayable skin barrier compositions comprising enzyme inhibitors derived from potatoes
Inventor: SAMBASIVAM MAHESH
Filed: 2006-06-19
Abstract: Disclosed is the use, in the preparation of a sprayable skin barrier composition for use in protecting perianal, perineal, peristomal and peri-wound skin, of: a barrier component based on oil, silicone, or petrolatum or a combination thereof; and an enzyme inhibiting component comprising one or more inhibitors derived from potatoes.
Patent NZ-548800-A (NZ)
Title: Test element and method for testing bag and receptor blood before a blood transfusion
Inventor: SCHWIND PETER
IPC: B01L3/00
Filed: 2005-02-02
Abstract: Disclosed is a method for testing blood during preparation and performance of bedside-tests. The method comprises: testing donor blood located within a blood bag to be potentially transfused into a recipient, by using a first test unit of a test element and obtaining a result; subsequently fixing the test element to the blood bag; thereafter testing blood from the recipient by applying a sample of the recipient's blood to a second test unit of the test element, while the test element is fixed to the blood bag, and obtaining a second result; and comparing the first and second test results on the test element in order to determine whether the donor blood is compatible for transfusion into the patient.
Patent NZ-550325-A (NZ)
Title: Method and apparatus to allow customers to initiate call center contact
Inventor: SMITH J TIMOTHY
IPC: H04M7/00
Filed: 2005-02-16
Abstract: A method for allowing a customer to initiate call center contact is disclosed. The method comprises the steps of: (a) receiving, at a network operation center, a message to be transmitted to a customer; (b) transmitting the message to the customer; (c) waiting for a reply from the customer that relates to the message; (d) first determining whether the reply is received; (e) if the reply is received, second determining whether the reply is a positive reply; (f) if the reply is a positive reply, alerting the call center that the customer has indicated the positive reply; and (g) providing customer contact information to the call center so the call center can contact the customer.
Patent NZ-552405-A (NZ)
Title: Pyrrolidine containing antiviral compounds
Inventor: FLEURY MELISSA
IPC: A61K31/662
Filed: 2005-07-18
Abstract: Disclosed is a phosphorus containing pyrrolidinyl compound of formula I where the substituents are as disclosed in the specification. Also disclosed is a pharmaceutical composition containing a compound of formula I and the use of a compound of formula I for the manufacture of a medicament for treating hepatitis C or a hepatitis C associated disorder.
Patent NZ-553426-A (NZ)
Title: Use of erythropoietin for treating diabetes mellitus
Inventor: BAHLMANN FERDINAND HERMANN
Filed: 2003-07-25
Abstract: Disclosed is the use of erythropoietin for producing a pharmaceutical composition comprising a subpolycythemic EPO-dosis corresponding to a weekly dosis of 1 to 90 international units (IU) EPO/kg body weight for the therapy of diabetes mellitus.
Patent NZ-555376-A (NZ)
Title: Anhydrous crystalline monopotassium salt of raltegravir
Inventor: BELYK KEVIN M
IPC: C07D413/12
Filed: 2005-12-02
Abstract: Disclosed is the anhydrous crystalline potassium salt (Form 1) of Compound A (raltegravir, N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl] amino}ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide) which is characterized by an X-ray powder diffraction pattern obtained using copper Ká radiation which comprises 2è values in degrees of 5.9, 12.5, 20.0, 20.6 and 25.6; a differential scanning calorimetry curve, obtained at a heating rate of 10°C/min in a closed cup under nitrogen, exhibiting a single endotherm with a peak temperature of about 279°C. Also disclosed is a pharmaceutical composition which comprises an effective amount of a Form 1 crystalline potassium salt of Compound A as defined above and a pharmaceutically acceptable carrier. The use of the above potassium salt of Compound A in the preparation of a medicament for inhibiting HIV integrase is further disclosed, wherein the medicament is for the treatment or prophylaxis of infection by HIV or for treating, prophylaxis of or delaying the onset of AIDS in a subject in need thereof.
Patent NZ-555538-A (NZ)
Title: Method for preparation of organofluoro compounds in alcohol solvents
Inventor: CHI DAE YOON
IPC: C07C17/007
Filed: 2005-12-09
Abstract: Disclosed is a method for the preparation of organofluoro compounds containing fluorine-18 by reacting fluorine salt containing fluorine-18 with alkyl sulfonate in the presence of an alcohol of figure 1 as the solvent wherein R1, R2 and R3 are hydrogen or C1-18 alkyl group.
Patent NZ-565495-A (NZ)
Title: Production of canola protein isolate
Inventor: GOSNELL BRANDY
IPC: A23J1/14
Filed: 2006-06-30
Abstract: Disclosed is a method for the production of a canola protein isolate consisting predominantly of the 2S canola protein, which includes: extracting canola oil seed meal with an aqueous salt solution at an elevated temperature to preferentially extract the 2S protein from the canola oil seed meal in preference to the 7S and 12S proteins and to obtain a canola protein extract solution containing predominantly 2S protein; separating the canola protein extract solution from residual canola oil seed meal; and recovering from the canola protein extract solution a canola protein isolate having a protein content of at least 90 wt% (N x 6.25) and consisting predominantly of the 2S canola protein.
Patent NZ-570209-A (NZ)
Title: Method for manufacturing and device for inhibiting myopia progression by manipulating the curvature of a visual image and controlling off axis aberrations
Inventor: HO ARTHUR
IPC: A61F2/16
Filed: 2007-01-11
Abstract: Method for manufacturing and lens (810) for inhibiting myopia progression are disclosed. The device manipulates the curvature of a visual image and controls off axis aberrations by the repositioning of peripheral off-axis focal points relative to the retina to produce a stimulus for influencing the progression of myopic refractive error while controlling both the position of the central focal point (850) to provide clear zones of vision and simultaneously providing zones of controlled peripheral defocus to improve peripheral vision for selected directions.
Patent NZ-572731-A (NZ)
Title: soil sample collection device with auger moved through port in bucket, and soil stripper located other than directly over the port
Inventor: STAFFORD AARON DAVID
IPC: E21B49/02
Filed: 2008-11-12
Abstract: The device has a body typically in the shape of a bucket with a port extending through the bucket (typically as a tube extending above and below the bucket base). A soil testing auger is locatable into the port so as to uplift soil when turned. A stripper is located inwardly of the bucket body but other than directly over the port for stripping soil off the auger as necessary.
Patent NZ-574069-A (NZ)
Title: Multi-component filter providing multiple flavour enhancement for a smoking article such as a cigarette
Inventor: SEITERT HUGUES
IPC: A24D3/06
Filed: 2007-08-03
Abstract: Disclosed is a multiply layered filter for a cigarette or smoking article to impart flavour to the smoke as it is drawn through the filter. The filter (4) comprises a mouth end segment (12), a first flavour release segment (14) comprising plant leaf upstream of the mouth end segment and a second flavour release segment (16) comprising filtration material and a flavourant upstream of the first flavour release segment. The resistance to draw of the second flavour release segment is greater than the resistance to draw of the first flavour release segment and the resistance to draw of the second flavour release segment is greater than the resistance to draw of the mouth end segment. The multi-component filter preferably further comprises a rod end segment (18) comprising filtration material upstream of the second flavour release segment, which has a lower resistance to draw than the second flavour release segment.
Patent NZ-574249-A (NZ)
Title: Use of escin for the treatment of an allergy or a secondary disease of an allergy, mediated or caused by activated granulocytes
Inventor: GRASSAUER ANDREAS
IPC: A61K31/704
Filed: 2007-08-03
Abstract: Disclosed is the use of escin for the manufacture of a pharmaceutical preparation for the treatment of an allergy or a secondary disease of an allergy, mediated or caused by activated granulocytes.
Patent NZ-576997-A (NZ)
Title: Thienopyrimidinones for treatment of inflammatory disorders and cancers
Inventor: WHITE STEPHEN L
IPC: A61K31/519
Filed: 2007-11-13
Abstract: Disclosed are thieno[3,2-d]pyrimidin-4-one and thieno[2,3-d]pyrimidin-4-one derivatives as represented by the general formula (I), wherein one of Q1, Q2 or Q3 is S, and the other two are -CR1-; Z is a bond, O, NR2, alkylene or heteroalkylene; R3 is aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, each of which is optionally substituted with up to three R1, or R3 can be hydrogen if Z is not a bond; L is selected from the group consisting of -C(R2)2-, -C(R2)2-C(R2)2-, -C(R2)2-NR2- or -C(R2)2-S(O)n-; Het is a monocyclic aromatic or bicyclic aromatic ring system wherein at least two ring atoms are N, and Het is optionally substituted with up to three substituents; and wherein the remaining substituents are as defined herein. Further disclosed is a pharmaceutical composition which comprises a compound as defined above for the treatment conditions such as cancer, leukaemia, inflammatory disorders, immune disorders or hypertension.
Patent NZ-579193-A (NZ)
Title: Patch lock fitting for locating a mortice lock assembly in an edge recess of a glass door panel
Inventor: WRIGHT PETER JOHN
IPC: E05B9/06
Filed: 2009-08-21
Abstract: Disclosed is a patch lock fitting for locating a mortice lock assembly in a recess formed adjacent a side edge of a glass door panel. The fitting includes a substructure formed from a pair of plate members that has a cavity for receiving the lock and at least one spacer located between the plate members and the glass door panel so as to firmly locate the fitting in the recess. The substructure also has a zone which in use is occupied by the panel. The zone is positioned relative to the cavity so as to align the mortice lock assembly with the panel. The substructure is configured to facilitate connection of a front portion of the mortice lock assembly to the substructure.
Patent NZ-581007-A (NZ)
Title: Wear assembly with mounting section having leading side of greater width than trailing side
Inventor: OLLINGER CHARLES G
IPC: E02F9/28
Filed: 2008-05-06
Abstract: A wear member (14) for excavating equipment comprising a working section (21) and a mounting section (23) generally aligned along a longitudinal axis. The mounting section includes a socket for receiving a base (12) fixed to the excavating equipment, a leading side (25) adapted to be a forward surface during advance of the wear member through the ground during a digging operation, and a trailing side (27) adapted to be a rearward surface during advance of the wear member through the ground. The working section is that part of the wear member forward of the socket. The leading and trailing sides extend axially across the working and mounting sections. The leading side has a greater width than the trailing side in transverse cross sections perpendicular to the longitudinal axis along at least part of the working section and the mounting section.
Patent NZ-588087-A (NZ)
Title: Respiratory mask with an interface including a foam cushioning element with a clip
Inventor: VELISS LEE JAMES
IPC: A61M16/06
Filed: 2009-03-04
Abstract: 588087 A respiratory mask assembly includes a frame (20) having a channel and a cushioning element (30) including a clip portion adapted for interference seal and retention in the channel. The cushioning element includes an interfacing portion constructed from foam and having a wider width than the clip portion.
Patent NZ-588877-A (NZ)
Title: Methods of using corticotropin-releasing factor for the treatment of cancer
Inventor: EVANS-FREKE STEPHEN
IPC: A61K38/22
Filed: 2009-04-30
Abstract: Disclosed is the use of corticotropin releasing factor (CRF) at a total daily dose greater than 2 mg in the manufacture of a composition for preventing tumor progression in a human, wherein the composition is to be administered for more than 3 days.
Patent NZ-592295-A (NZ)
Title: System and method for scheduling demand response events in a network
Inventor: TYAGI RAJESH
IPC: G06Q30/02
Filed: 2011-04-15
Abstract: A system and a method of scheduling demand response events in a network are disclosed. The system (100) comprises a database (134) to store demand response data; a demand response module (128) to group customers into customer groups based on the demand response data, and to schedule one or more of the customer groups for a demand response event based on the demand response data and forecast data and a controller to implement the demand response event for the one or more customer groups scheduled for the demand response event. The scheduling of the one or more customer group occurs when an estimated current benefit of executing the demand response event associated with the group is greater than an expected future benefit.
Patent NZ-597379-A (NZ)
Title: Therapeutic compounds and compositions
Inventor: SAUNDERS JEFFREY O
IPC: C07D211/04
Filed: 2010-06-29
Abstract: 597379 Compounds of Formula I and compositions comprising said compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer. Compounds disclosed include: N-(4-(4-(2-methoxyphenyl)-1,4-diazepane-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(pyrimidin-2-yl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(pyrazin-2-yl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-( 4-(4-(2-fluorophenyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(3-isopropoxyphenyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(2-methoxypyridin-3-yl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(3-(Thiophen-2-yl)propanoyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(1,2,3-Thiadiazole-4-carbonyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(1H-Pyrrole-2-carbonyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(Thiazole-4-carbonyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(2-Cyclopropylacetyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-(4-(Cyclohexanecarbonyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide N-(4-Cyanophenyl)-4-(4-(quinoline-8-sulfonamido)benzoyl)piperazine-1-carboxamide (Tetrahydrofuran-2-yl)methyl 4-(4-(quinoline-8-sulfonamido)benzoyl)piperazine-1-carboxylate and 1-Methylazetidin-3-yl 4-(3-methyl-4-(quinoline-8-sulfonamido)benzoyl)piperazine-1-carboxylate
Patent NZ-599670-A (NZ)
Title: Diagnostic and therapeutic methods for rheumatic heart disease based upon group a streptococcus markers
Inventor: MARGARIT Y ROS IMMACULADA
IPC: G01N33/564
Filed: 2010-10-20
Abstract: NZ 599670 Disclosed is the use of at least one Group A Streptococcus (GAS) antigen or a functional equivalent thereof in the preparation of a medicament for treatment or prevention of rheumatic heart disease (RHD) associated with Group A Streptococcus (GAS) infection, wherein the at least one GAS antigen or functional equivalent thereof is selected from the group consisting of: a GAS5 antigen comprising an amino acid sequence set forth in SEQ ID NO: 1; a GAS5F antigen comprising an amino acid sequence set forth in SEQ ID NO: 2; a GAS25 antigen comprising an amino acid sequence set forth in SEQ ID NO: 3; a GAS40 antigen comprising an amino acid sequence set forth in SEQ ID NO: 4; a GAS57 antigen comprising an amino acid sequence set forth in SEQ ID NO: 5; a GAS97 antigen comprising an amino acid sequence set forth in SEQ ID NO: 6; a GAS380 antigen comprising an amino acid sequence set forth in SEQ ID NO: 7; and a SpeA antigen comprising an amino acid sequence set forth in SEQ ID NO: 8, wherein the sequences are as defined in the complete specification.